date:Oct 26, 2018
ne months of 2018 was 28.2 percent despite headwind from currencies. For full-year 2018 Novozymes still expect an EBIT margin of around 28 percent including a negative impact from currencies, as well as a higher activity level on the commercial side, to support growth opportunities, particularly in emerging markets.
As currencies are experiencing high volatility, in particular, the US dollar, a weakening relative to what has been assumed in the guidance for the full year (USD/DKK at 6.31) could